Skip to main content

Table 1 Baseline characteristics of HGG patients

From: Determining optimal clinical target volume margins in high-grade glioma based on microscopic tumor extension and magnetic resonance imaging

Characteristic No. (%)
Gender  
 Male 16 (53.3)
 Female 14 (46.7)
Age (years)  
  ≤ 60 24 (80)
  > 60 6 (20)
Preoperative KPS  
 80–90 8 (26.7)
  ≥ 90 22 (73.3)
Pathologic grade  
 Grade III 17 (56.7)
 Grade IV 13 (43.3)
Tumor volume (cm3)  
 Median (IQR) 20.04 (10.68–42.92)
 Range 1.83–80.66
PTBE volume (cm3)  
 Median (IQR) 105.26 (56.92–137.37)
 Range 17.2–235.65
Tumor location  
 Type I 11 (36.7)
 Type II 9 (30)
 Type III 10 (33.3)
Molecular markers  
 MGMT methylation status  
  Unmethylated 12 (40)
  Methylated 18 (60)
 IDH mutation status  
  Mutated 12 (40)
  Wild type 18 (60)
 1p/19q co-deletion status  
  Co-deleted 11 (36.7)
  Non-co-deleted 19 (63.3)
  1. HGG high-grade glioma; KPS Karnofsky performance status; IQR interquartile range; PTBE peritumoral brain edema; MGMT O6-methylguanine-DNA-methyltransferase; IDH isocitrate dehydrogenase; 1p/19q co-deletion the co-deletion of chromosome arms 1p and 19q